• PDF: Delivered by email usually within 12 to 24 UK business hours.

Laboratoires Takeda - Product Pipeline Review
Q4 2010

Laboratoires Takeda - Product Pipeline Review Q4 2010

Laboratoires Takeda - Product Pipeline Review - Q4 2010

Summary

Global Market Direct's pharmaceuticals report, "Laboratoires Takeda - Product Pipeline Review - Q4 2010" provides data on the company's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. It also gives a complete picture of the company's future therapy areas of focus.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, primary and secondary research using Company's corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by Global Markets Direct's team of industry experts.

Scope

  • Laboratoires Takeda - company overview including business description, key employees, and other facts.
  • Review of current pipeline of Laboratoires Takeda human therapeutic division.
  • Overview of pipeline therapeutics across various therapy areas.
  • Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, for the pharmaceutical markets across the globe.
  • Product profiles for late stage and clinical stage products of Laboratoires Takeda with complete description of the product's developmental history, mechanism of action, clinical trials, major milestones and others.
  • Recent updates of the Laboratoires Takeda's pipeline in the last quarter.
  • Key discontinued and dormant projects.
  • Latest news and deals relating to the products.

Reasons to buy

  • Evaluate Laboratoires Takeda's strategic position with total access to a detailed intelligence on its product pipeline.
  • Assess the growth potential of Laboratoires Takeda in its therapy areas of focus.
  • Identify new drug targets and therapeutic classes in the Laboratoires Takeda's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
  • Exploit collaboration and partnership opportunities with Laboratoires Takeda.
  • Avoid Intellectual Property Rights related issues.
  • Explore the dormant and discontinued projects of Laboratoires Takeda and identify potential opportunities in those areas.
  • Do deals with an understanding of the mergers and partnerships that have shaped the sector.
  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Introduction
  • 3 Laboratoires Takeda Snapshot
    • 3.1 Business Description
  • 4 Laboratoires Takeda- Research and Development Overview
    • 4.1 Key Therapeutic Areas
  • 5 Laboratoires Takeda- Pipeline Review
    • 5.1 Pipeline Products by Stage of Development
    • 5.2 Pipeline Products-Monotherapy
    • 5.3 Pipeline Products-Combination Treatment Modalities
  • 6 Laboratoires Takeda Pipeline Products Glance
    • 6.1 Laboratoires Takeda Phase II Pipeline
    • 6.2 Laboratoires Takeda Phase I Pipeline
    • 6.3 Laboratoires Takeda Pre-Clinical Pipeline
  • 7 Laboratoires Takeda - Drug Profiles
    • 7.1 Product 1
    • 7.1.1 Product Description
    • 7.1.2 Mechanism of Action
    • 7.1.3 R&D Progress
  • 8 Laboratoires Takeda Pipeline Analysis
    • 8.1 Laboratoires Takeda Pipeline Products by Therapeutic Class
    • 8.2 Laboratoires Takeda Pipeline Products by Target
    • 8.3 Laboratoires Takeda Pipeline by Route of Administration
    • 8.4 Laboratoires Takeda Pipeline Products by Molecule Type
  • 9 Laboratoires Takeda- Recent Pipeline Updates
  • 10 Laboratoires Takeda- Dormant Pipeline Projects
    • 10.1 Feature on Dormant Projects
  • 11 Laboratoires Takeda- Discontinued Pipeline Products
    • 11.1 Discontinued Pipeline Product Profiles
    • 11.1.1 Product 1
  • 12 Laboratoires Takeda - Featured News
  • 13 Laboratoires Takeda Statement
    • 13.1 Laboratoires Takeda - Locations and Subsidiaries
  • 14 Appendix
    • 14.1 Global Markets Direct Research Methodology
    • 14.2 Coverage
    • 14.3 Secondary Research
    • 14.4 Primary Research
    • 14.5 Models
    • 14.6 Expert Panels
    • 14.7 Contact Us
    • 14.8 Disclaimer
  • 1.1 List of Tables
    • Table 1: Laboratoires Takeda - Key Information
    • Table 2: Laboratoires Takeda - Key Facts
    • Table 3: Laboratoires Takeda - Key Therapeutic Areas
    • Table 4: Laboratoires Takeda - Pipeline by Stage of Development, 2010
    • Table 5: Laboratoires Takeda - Monotherapy Products in Pipeline, 2010
    • Table 6: Laboratoires Takeda - Combination Treatment Modalities in Pipeline, 2010
    • Table 7: Laboratoires Takeda - Phase II Pipeline, 2010
    • Table 8: Laboratoires Takeda - Phase I Pipeline, 2010
    • Table 9: Laboratoires Takeda - Pre-Clinical Pipeline, 2010
    • Table 10: Laboratoires Takeda - Pipeline By Therapeutic Class
    • Table 11: Laboratoires Takeda - Pipeline By Target
    • Table 12: Laboratoires Takeda - Pipeline By Route of Administration
    • Table 13: Laboratoires Takeda - Pipeline By Molecule Type
    • Table 14: Laboratoires Takeda - recent Pipeline Updates
    • Table 15: Laboratoires Takeda - Dormant Pipeline Projects
  • 1.2 List of Figures
    • Figure 1: Laboratoires Takeda - Research and Development Overview
    • Figure 2: Laboratoires Takeda - Pipeline by Stage of Development, 2010
    • Figure 3: Laboratoires Takeda - Monotherapy Products in Pipeline, 2010
    • Figure 4: Laboratoires Takeda - Combination Treatment Modalities in Pipeline, 2010
    • Figure 5: Laboratoires Takeda - Pipeline By Therapeutic Class and Stage of Development
    • Figure 6: Laboratoires Takeda - Pipeline By Therapeutic Class
    • Figure 7: Laboratoires Takeda - Pipeline By Target and Stage of Development
    • Figure 8: Laboratoires Takeda - Pipeline By Target
    • Figure 9: Laboratoires Takeda - Pipeline By Route of Administration and Stage of Development
    • Figure 10: Laboratoires Takeda - Pipeline By Route of Administration
    • Figure 11: Laboratoires Takeda - Pipeline By Molecule Type and Stage of Development
    • Figure 12: Laboratoires Takeda - Pipeline By Molecule Type
+44 20 8816 8548

Ask a question about Laboratoires Takeda - Product Pipeline Review

Enter the characters you see in the picture below
Captcha